Notice: An IPO for DGX is planned for Monday, December 23, 2024

Quest Diagnostics (DGX) Stock Forecast & Price Target

$151.51 -3.98 (-2.56%)

(As of 02:52 PM ET)

Quest Diagnostics - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
0

Hold
8

Buy
7

Based on 15 Wall Street analysts who have issued ratings for Quest Diagnostics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 8 have given a hold rating, 6 have given a buy rating, and 1 has given a strong buy rating for DGX.

Consensus Price Target

$169.15
11.65% Upside

According to the 15 analysts' twelve-month price targets for Quest Diagnostics, the average price target is $169.15. The highest price target for DGX is $185.00, while the lowest price target for DGX is $135.00. The average price target represents a forecasted upside of 11.65% from the current price of $151.51.

Get the Latest News and Ratings for DGX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors.

DGX Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	5 Buy rating(s)	4 Buy rating(s)	2 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$169.15	$164.58	$154.33	$147.58
Forecasted Upside	11.65% Upside	1.53% Upside	-0.51% Downside	8.16% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Hold	Hold

Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

DGX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DGX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Quest Diagnostics Stock vs. The Competition

Type	Quest Diagnostics	Medical Companies	S&P 500
Consensus Rating Score	2.53	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	8.78% Upside	28,526.49% Upside	12.03% Upside
News Sentiment Rating	Positive News See Recent DGX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	Morgan Stanley 3 of 5 stars		Upgrade	Equal Weight ➝ Overweight	$145.00 ➝ $172.00	+12.65%
12/13/2024	Bank of America 3 of 5 stars		Boost Target	Buy ➝ Buy	$179.00 ➝ $182.00	+16.56%
12/10/2024	Jefferies Financial Group 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$175.00 ➝ $185.00	+16.97%
10/28/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$150.00 ➝ $165.00	+5.85%
10/24/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$160.00 ➝ $174.00	+10.74%
10/23/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Coldwell Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
Get the Latest News and Ratings for DGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter.
10/23/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$165.00 ➝ $166.00	+6.52%
10/23/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$154.00 ➝ $168.00	+6.69%
10/23/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$165.00 ➝ $185.00	+17.48%
10/23/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Outperform	$157.00 ➝ $182.00	+15.58%
10/7/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$158.00 ➝ $165.00	+9.42%
8/28/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	In-Line	$165.00	+7.38%
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$152.00 ➝ $155.00	+11.64%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$135.00	+6.23%
2/3/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight	$135.00 ➝ $140.00	-0.44%
1/25/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$143.00 ➝ $146.00	+0.75%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:59 PM ET.

DGX Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Quest Diagnostics is $169.15, with a high forecast of $185.00 and a low forecast of $135.00.
: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Quest Diagnostics in the last twelve months. There are currently 8 hold ratings, 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DGX shares.
: According to analysts, Quest Diagnostics's stock has a predicted upside of 11.65% based on their 12-month stock forecasts.
: Over the previous 90 days, Quest Diagnostics's stock had 3 upgrades by analysts.
: Quest Diagnostics has been rated by research analysts at Baird R W, Bank of America, Barclays, Citigroup, Jefferies Financial Group, Mizuho, Morgan Stanley, Piper Sandler, Robert W. Baird, Truist Financial, and UBS Group in the past 90 days.
: Analysts like Quest Diagnostics less than other "medical" companies. The consensus rating score for Quest Diagnostics is 2.53 while the average consensus rating score for "medical" companies is 2.81. Learn more on how DGX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This drone stock is setting up to transform medical supply delivery (Ad)

Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.

Click here to see how a new partnership could catapult this drone suppliers' growth

This page (NYSE:DGX) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quest Diagnostics (DGX) Stock Forecast & Price Target